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Abstract-Little is known about how generosity of insurance and population characteristics affect 
quantity or appropriateness of antibiotic use. Using insurance claims for antibiotics from 5765 
non-elderly people who lived in six sites in the United States and were randomly assigned to 
insurance plans varying by level of cost-sharing, we describe how antibiotic use varies by insurance 
plan, diagnosis and health status, geographic area, and demographic characteristics. People with 
free medical care used 85% more antibiotics than those required to pay some portion of their 
medical bills (controlling for all other variables). Antibiotic use was significantly more common 
among women, the very young, patients with poorer health, and persons with higher income. Use 
of antibiotics for viral, viral-bacterial, and bacterial conditions did not differ between free and 
cost-sharing insurance plans, given antibiotics were the treatment of choice. Cost sharing reduced 
inappropriate and appropriate antibiotic use to a similar degree. 
Antibiotics Drugs Health Insurance Experiment Cost sharing Utilization 
Controlled trial Ambulatory care Prescribing practice 
INTRODUCTION 
THE VOLUME of antibiotics used in this country 
is enormous, 105 million prescriptions in 1980 
[l], but surprisingly little is known about their 
use in the general population. Even descriptive 
data relating antibiotic use to demographics 
tends to be limited to those gleaned from special 
groups such as Medicaid recipients [2,3]. 
*Requests for reprints should be sent to Dr R. Valdez. The 
Rand Corporation, 1700 Main Street, Santa Monica, 
CA 90406-9972, U.S.A. 
The views expressed are those of the authors and do not 
necessarily represent those of the Department of Health 
and Human Services or The Rand Corporation. 
Supported by a Health Insurance Study Grant (016B80) 
from the Department of Health and Human Services, 
Washington, DC. 
Antibiotics used appropriately or inap- 
propriately can produce iatrogenic disease. 
Concern over inappropriate use [2-81 has led to 
the development of programs aimed at changing 
physician’s antibiotic prescribing habits [24]. 
Such programs do not, however, ease problems 
of restricted access to necessary antibiotic ther- 
apy owing to financial barriers such as inade-‘ 
quate insurance coverage. Providing free medi- 
cal care to all persons increases access to care. 
This could improve the quality of antibiotic use, 
but it could just as likely increase both inap- 
propriate antibiotic use and harmful side effects. 
To understand how antibiotics are used, we 
analyzed data from insurance claims collected 
as part of the Rand Health Insurance Experi- 
ment. We describe how the use of antibiotics in 
a general non-elderly population varies by gen- 
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erosity of insurance, patient demographics, geo- 
graphic area of the United States, health status, 
and diagnosis, 
METHODS 
The Rand Health Insurance Experiment 
Data for this paper come from the Health 
Insurance Experiment (HIE). The HIE was a 
unique social experiment designed to provide 
better information than heretofore available on 
the effects of alternative health insurance ar- 
rangements. Families participated in the experi- 
ment from November 1974 to January 1982. 
Details of the experimental design, other than 
those described here, can be found elsewhere 
[9, 101. 
Briefly, 5814 individuals from 2005 families 
were enrolled in the fee-for-service part of the 
experiment; 70% participated for 3 years, the 
remainder for 5. Families lived in one of six 
sites: Dayton, OH; Seattle, WA; Fitchburg 
or Franklin County, MA; and Charleston or 
Georgetown County, SC. 
Families with very high incomes were ex- 
cluded from the experiment. About 3% of the 
families contacted were excluded from the ex- 
periment because their annual income exceeded 
$58,000 (in 1984 dollars). Also excluded were 
families in which the head of household was 
eligible for Medicare or who would become so 
before the end of the study. Additionally, fam- 
ilies participating in the Supplemental Security 
Income (SSI) program, those eligible for the 
military medical system, and institutionalized 
individuals (e.g. in prison or in mental institu- 
tions) were excluded. Except for these in- 
tentional differences, families were representa- 
tive of the general population of the area where 
they resided [9]. 
Families electing to enroll in the experiment 
were assigned to one of 14 fee-for-service insur- 
ance plans by a random-sampling method that 
made the distribution of family characteristics 
as similar as possible in each plan [lo]. For the 
analyses presented here, each plan was assigned 
to one of two categories. First, in the free- 
care plan, families received all medical services 
free of charge (0% coinsurance). The second 
category comprised all the cost-sharing plans, in 
which families paid 25, 50, or 95% of their 
medical bills out-of-pocket up to a stipulated 
maximum each year that was tied directly to 
family income. All plans covered with the same 
assigned coinsurance rate all ambulatory and 
hospital care, most dental services, mental 
health services, visual and auditory services, 
prescription drugs and supplies. 
Sources of antibiotic data 
To be reimbursed for oral prescription drugs, 
participants submitted insurance claim forms 
that were usually completed by a pharmacist. 
Injected drugs were usually billed as part of a 
claim for physician services. Our analysis is 
based on claims submitted by 5765 individuals 
who participated for the entire second year of 
the experiment. We included all claims for anti- 
biotics provided in an ambulatory setting (i.e. 
not a hospital or nursing home) and grouped 
them into the following classes: amoxicillin/ 
ampicillin; all other penicillins; tetracyclines; 
erythromycin; sulfonamides; cephalosporins; 
lincomycin and clindamycin; polymyxins; chlor- 
amphenicol; aminoglycosides; and nitrofurans. 
The quantity of pills prescribed per prescription 
and dosage levels used did not vary by plan, so 
we did not adjust for these factors in our 
analyses. 
Assigning diagnoses to antibiotics 
We linked each antibiotic to a specific diagno- 
sis. Most often, the prescribing physician made 
the diagnosis link and recorded it on the insur- 
ance form. In a few cases multiple diagnoses 
were recorded and not linked to drug therapy. 
After reviewing a complete patient profile, a 
physician at Rand (GAG), who was blinded to 
the insurance coverage of the patient, assigned 
the diagnosis that probably triggered the anti- 
biotic therapy. When an antibiotic could be 
linked to two diagnoses (2% of the total), 
the first diagnosis listed by the physician was 
counted. A diagnosis could be determined for 
3793 of 3903 antibiotic claims (97%). 
After linking each antibiotic to a diagnosis, 
we coded diagnoses into 150 homogeneous 
groups (an expanded version of an earlier listing 
of 92 “diagnosis clusters” [l 11). Finally, we 
specified four diagnostic categories for which 
antibiotics might be appropriately or inap- 
propriately prescribed (Table l), according to 
whether an illness was likely to be bacterial 
(e.g. streptococcal sore throat) or viral (e.g. 
influenza) or to be one for which antibiotics are 
standard therapy (e.g. acne). 
Estimating use of antibiotics by patient charac- 
teristics and insurance plan 
We examined differences between groups 
(such as adults and children or persons who 
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Table 1. Diagnostic categories used for antibiotic analyses 
I. Usually viral conditions 
Acute upper respiratory infection 
Influenza 
Cough (as a primary diagnosis) 
Throat pain, tonsillar hypertrophy (as primary 
diagnoses) 
Viral rashes or exanthems 
Chronic rhinitis/hay fever* 
II. Viral/bacterial conditions 
Acute pharyngitis and tonsillitis 
Acute laryngitis and tracheitis 
Acute bronchitis 
III. Usually bacterial conditionst 
A. Respiratory infections and conditions 
Otitis media 
Sinusitis 
Streptococcal sore throat 
Pneumonia 
index. The health ratings index, an indicator of 
underlying health status, was computed from 
22 questionnaire items (7 for children 13 and 
younger) administered to all participants at the 
beginning of the second participation year 
[13, 141. The distribution of antibiotics pur- 
chased was skewed and non-normal, with most 
people using none or only one antibiotic per 
year and a few individuals using as many as 20; 
to account for this, we fit a negative binomial 
model to the data [15]. 
RESULTS 
Emphysema, chronic bronchitis, chronic 
obstructive pulmonary disease 
Asthma 
B. Non-respiratory infections and conditions 
Sexually transmitted diseases and 
pelvic inflammatory disease 
Conjunctivitis and keratitis 
We present univariate and multivariate analy- 
ses on how antibiotic use differs with patient’s 
personal characteristics, demographics, insur- 
ance coverage, and diagnosis. 
Urinary tract and prostate infections 
Vaginitis and cervicitis 
Acne 
Other skin infections or inflammation (all types) 
Lacerations, contusions, and other injuries 
IV. All other conditions1 
*Hay fever is included here because using antibiotics to treat 
hay fever is analogous to using antibiotics to treat viral 
conditions. 
tNot all of these conditions are bacterial in the strict 
medical sense, but they are included in this category 
because antibiotic or other antimicrobial usage is accepted, 
standard therapy when an infection is considered present. 
$A11 other diagnoses and problems for which care was 
obtained in the second year of the experiment. 
Types of Antibiotics used by Children and Adults 
Among children (< 14 yr of age) the most 
commonly used oral antibiotics were 
amoxicillin/ampicillin (35%), penicillins (30%), 
and erythromycin (17%) (Table 2). Two percent 
of the antibiotics prescribed for children were 
tetracyclines (about three-quarters of which 
were for children 9 or older). Among adults, 
tetracyclines (25%) were the most commonly 
used antibiotic, followed by relatively equal 
use of penicillins, amoxicillin/ampicillin, and 
erythromycin. 
were in good or poor health) with multi-level 
contingency tables and simple descriptive statis- 
tics. We then determined the rate of antibiotic 
use for each level of the variable of interest and 
calculated ratios of those rates (e.g. the ratio of 
the rate of antibiotic use among women to that 
among men). A Taylor’s series 95% confidence 
interval was calculated for each ratio [12]. If the 
confidence interval does not include 1.0, the 
difference between the two groups is statistically 
significant at the 0.05 level (two-tailed test). 
Injectable antibiotics accounted for 10% of 
total antibiotic use. The most commonly injec- 
ted agents were the penicillins (children, 82% of 
all injectable antibiotics; adults, 48%). Among 
children, the second-ranking injectable anti- 
biotics were amoxicillin/ampicillin (8%) fol- 
lowed by lincomycin or clindamycin (4%). 
Among adults, the next two commonly injected 
antibiotics were lincomycin or clindamycin 
(28%) and tetracyclines (17%). 
Relationship of Antibiotic Use to Demographic 
and Plan Variables 
Age and sex 
To explain antibiotic use while controlling for Taking all insurance plans together, children 
the effects of several variables simultaneously, 6 yr and younger used oral antibiotics most 
we used multiple regression techniques. The frequently: more than 1 antibiotic per child per 
number of prescriptions purchased during the year (Table 3). After age 6, boys and men used 
second year of the experiment was the de- between 0.33 and 0.42 antibiotics per year. 
pendent variable. Explanatory variables were Among girls and women, antibiotic use dropped 
insurance plan, HIE site, income adjusted for by about one-half for adolescent and teenaged 
site cost-of-living differences and family size and girls, but then rose to 0.72 antibiotics per 
composition, age, age squared, sex, and a women per year after age 20. Overall, women 
person-specific score on a general health ratings were 1.46 times (confidence interval (CI): 1.40, 
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Table 2. Number and percentage of oral antibiotics purchased for children and adults, by 
antibiotic class 
Antibiotic class 
Children (< 14 yr) 
N = 1775 
Number of Percent of 
antibiotics antibiotics* 
Adults (> 14 yr) 
N = 3907 
Number of Percent of 
antibiotics antibiotics* 
Penicillins 414 30 311 15 
Amoxicillin/ampicillin 471 35 278 13 
Erythromycin 231 17 309 15 
Tetracychnes 30 2 536 25 
Cephalosporins 41 3 124 6 
Lincomycin/chndamycin 2 <I 23 1 
Sulfonamides 49 4 69 3 
Nitrofurans 21 2 69 3 
Aminoglycosides 4 <I II 1 
Antifungals 22 2 246 12 
Combinations 55 4 99 5 
Other 12 1 38 2 
Total I364 101 2113 101 
*Percentages may not sum to 100 because of rounding. Age was unknown for 83 people. 
1.53) as likely to use an oral antibiotic as were 
men. 
Injected antibiotics per person per year aver- 
aged 0.07. Injections were most common among 
children 6 and younger (0.09) and among adults 
40 and older (0.12). As with oral antibiotics, 
injections were more common among women 
than men (0.08 and 0.06 per person per year; 
female:male ratio, 1.31; CI: 1.08, 1 S8). 
Health status 
Even though most antibiotics are used for 
acute conditions, we expected them to be used 
mainly by individuals in poorer health. To test 
this hypothesis, we calculated rates of use for 
persons who were considered to be in “ill 
health” at the beginning of the second study 
year according to values on a self- or parent- 
assessed general health ratings index. 
All persons whose score on this index was 
below the median for their age and sex group 
used more antibiotics annually than those with 
better-than-average health status. Oral anti- 
biotics were 1.47 times as likely to be used (CI: 
1.41, 1.54) if people perceived their health to be 
poorer than average (0.72 vs 0.49); injectable 
antibiotics were 1.35 times (CI: 1.12, 1.63) as 
likely to be used (0.08 vs 0.06). 
Insurance plan 
Age and plan. Children with free care used 
73% more antibiotics (CI: 68, 78) than those on 
the cost-sharing plans, and adults on the free 
plan 86% more (CT: 78, 94). Altogether, par- 
ticipants on the free care plan used 80% more 
antibiotics than did people on the cost-sharing 
plans (CI: 75, 86). 
Site andplan. Annual per capita antibiotic use 
varied by geographic area. Oral antibiotic use 
was highest in Dayton (0.87 antibiotics per 
person per year) and lowest in Massachusetts 
(0.43); Seattle (0.62) and South Carolina (0.59) 
fell between the two. Dayton physicians also 
gave injectable antibiotics more frequently than 
physicians in any other site: 0.24 injections per 
person per year compared with 0.01 in Massa- 
chusetts and 0.04 in both Seattle and South 
Carolina. 
Table 3. Use of oral antibiotics per person per year by age and sex 
Women Men 
Age group Number of Number Number of Number 
(yr) Number antibiotics per person Number antibiotics per person 
@6 390 470 1.21 438 519 1.18 
7-13 465 217 0.47 482 158 0.33 
1419 360 204 0.57 380 158 0.42 
20-29 563 428 0.76 447 166 0.37 
3&39 515 335 0.65 459 142 0.31 
40-49 283 191 0.67 261 100 0.38 
50 and over 365 282 0.77 274 107 0.39 
Total* 2992 2138 0.71 2713 1357 0.49 
*Age was unknown for 51 women and 32 men (I 1 claims for women and 7 for men) 
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Table 4. Use of oral, injected, and all antibiotics per person per year by level of family income and 
insurance plan 
Free plan Cost-sharing plans 
(N = 1935) (N = 3830) Ratio of free 
to cost-sharing 
Antibiotic use and Number of Number per Number of Number per (95% confidence 
income tertile’ antibiotics person antibiotics person interval)? 
Oral antibiotics 
Upper one-third 548 0.94 723 0.58 1.63 (1.55, 1.72) 
Middle one-third 577 0.93 669 0.57 1.62(1.53, 1.71) 
Lower one-third 442 0.72 386 0.33 2.17 (1.97,2.39) 
All incomes 1670 0.85 1825 0.48 1.79(1.72, 1.86) 
Injected antibiotics 
Upper one-third 45 0.08 89 0.07 1.09 (0.77, I .54) 
Middle one-third 69 0.11 75 0.06 1.73 (1.27.2.36) 
Lower one-third 38 0.06 45 0.04 1.60 (1.05,2.44) 
All incomes 187 0.10 221 0.06 1.67 (1.39,2.01) 
All antibiotics 
Upper one-third 593 1.02 812 0.65 1.57 (1.51, 1.63) 
Middle one-third 646 1.04 744 0.64 1.63 (1.57, 1.70) 
Lower one-third 480 0.78 431 0.37 2.11 (1.94,2.30) 
All incomes 1857 0.96 2046 0.53 1.80 (1.75, 1.86) 
*Numbers shown for income tertiles do not sum to totals because income was unknown for 138 claims 
on the free plan and 59 on the cost-sharing plans. 
tTavlor’s series 95% confidence intervals 1121; ratio and confidence intervals calculated using 8 
significant digits. 
_ _ 
For all geographic areas, use of oral anti- 
biotics was ‘higher with free care. Plan 
differences were greatest in South Carolina: 
persons on the free plan used 134% more 
antibiotics (CI: 119, 151). Differences were 
smallest in Seattle: 30% more (CI: 19, 42). 
Family income and plan. Regardless of plan, 
people in the lowest third of the income distri- 
bution (adjusted for geographic area) used the 
fewest antibiotics (Table 4). Having free care 
significantly diminished the effect of income on 
use of antibiotics. With free care, persons in the 
highest income group used about one-third 
more antibiotics than did those in the lowest 
income group; on the cost-sharing plans, use 
among persons with the highest incomes was 
about three-quarters again as great. 
For oral antibiotics the largest free-to-cost- 
sharing ratio occurred among persons in the 
lowest income group (Table 4); their ratio of 
2.17 was significantly different from those of 
persons in the middle or upper thirds of the 
income distribution. People in the lowest in- 
come tertile had the fewest injections regardless 
of insurance plan; poor people on the free plan 
used 60% more injected antibiotics than those 
on the cost-sharing plans. 
Eflects of insurance plan, income, age, sex, site, 
ill health on use of oral antibiotics 
Antibiotic use was associated with several 
demographic and experimental variables when 
examined one at a time. To understand the 
collective and separate effects of these variables, 
we used a negative binomial regression model to 
estimate the rate of oral antibiotic use [16]. Cost 
sharing, older age, being male, having lower 
income, and being in better health were all 
significantly associated with using fewer oral 
antibiotics per person per year. The ratios pro- 
duced by the model are very close to those 
found in the univariate and bivariate analyses. 
For example, even when no other variables are 
controlled for, individuals on the free plan used 
80% more antibiotics than those on the cost- 
sharing plans; when age, sex, income, health 
status, and geographic area are held constant, 
we estimate 85% more antibiotic use on the free 
plan. These similarities are not surprising be- 
cause demographic characteristics were bal- 
anced across plans at the beginning of the 
experiment. 
Table 5 presents several examples of annual 
rates of oral antibiotic use predicted by our 
multivariate model, holding geographic site and 
health status constant. For example, we esti- 
mate that high-income girls on the free plan 
used 2.48 antibiotics per year (the highest rate 
among the various groups examined); at 0.09 
per year, low-income men on the cost-sharing 
plan used the fewest antibiotics. 
We can use these examples to address more 
concretely two important questions: “Given 
that a person is poor, how much more will that 
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Table 5. Annual per-person rate* of oral antibiotic use 
for persons of different family income, sex, and ages by 
insurance plan 
Free plan Cost-sharing plans 
Low High Low High 





1.82 2.48 1.06 1.14 
0.49 0.67 0.14 0.53 
4 yr 1.15 1.57 0.67 0.72 
45 yr 0.31 0.42 0.09 0.33 
*Per-person rates are predicted using a negative binomial 
model [16] holding health status and geographic site 
constant. 
person use antibiotics if he or she has free 
medical care rather than shares in the cost of 
care?’ and “If people have free care, how much 
will use of antibiotics differ between those who 
are poor and those who are well-to-do?” Having 
free care markedly increases the use of anti- 
biotics: compared with individuals in the cost- 
sharing plans, poor women with free care use 
about 250% more antibiotics ([0.49 - 0.14]/ 
0.14 = 2.50); poor men use about 244% more; 
and poor children about 72% more. Even 
with free care, however, use would continue 
to differ by income level. Poor persons with 
free care use about 27% fewer antibiotics than 
well-off persons (e.g. [2.48 - 1.82]/2.48 = 0.27 
for 4-year-old girls). 
Antibiotic use by diagnosis 
One way to determine if different levels of 
cost sharing (including none) are associated 
with over- or under-use of antibiotics is to see 
if the proportions of antibiotics given for vari- 
ous diagnostic categories differ. We calculated 
the percentage distribution of all antibiotics 
across four broad diagnostic categories-viral, 
viral-bacterial, bacterial, and other; these dis- 
tributions did not differ appreciably by plan 
(Table 6). Viral conditions such as upper respir- 
atory infections, for which the indications for 
antibiotic use are equivocal at best, accounted 
for 17 and 16% of antibiotics purchased on the 
free and cost-sharing plans, respectively. The 
percentages of antibiotics that were used for the 
viral-bacterial, bacterial, and other categories 
were also nearly identical for the two plans. 
Individuals with free care used more anti- 
biotics per person than those on the cost-sharing 
plans for all four diagnostic categories. The 
differential extended from 56% more for 
viral-bacterial conditions to 97% more for viral 
conditions. Yet, other results from the Health 
Insurance Experiment show no significant 
differences in health status for the average 
participant by insurance plan [17, 181. 
DISCUSSION 
We have shown that insurance coverage, sex, 
age, geographic area, health status, and income 
influenced antibiotic use. People with more gen- 
erous insurance use 85% more antibiotics per 
person per year than people who shared in the 
costs of their medical care, even controlling for 
the influence of demographic and personal 
characteristics. Being female, being young, 
being in “ill health” (below the median of a 
parent- or self-assessed health ratings index), 
and being of higher income led to significantly 
higher rates of antibiotic use. 
Other work in the Health Insurance Experi- 
ment has shown that annual drug expenditures 
in an ambulatory setting rise as the level of cost 
sharing falls [19]. Drug expenditures per person 
on the free care plan were about 60% higher 
than on our least generous plans (95% co- 
insurance). This increase in total drug expen- 
ditures is about the same as that observed for 
total per capita outpatient expenditures and 
suggests that drug use increased at the same 
rate as did physician visits. The number of 
total prescriptions purchased per person was 
significantly higher on the free plan and varied 
across plans in the same fashion as did drug 
expenditures. Finally, no difference was found 
by plan for average charge per prescription so 
plan differences are related to the quantity of 
drugs purchased. Thus, the effect of cost sharing 
on antibiotic use comes principally through a 
reduction in visits rather than as a result of 
reduced antibiotic prescribing given a visit. 
The types of antibiotics purchased were simi- 
lar for participants on the free and cost-sharing 
plans. Moreover, the pattern was consistent 
with that reported by the National Ambulatory 
Medical Care Survey [1], so our experimental 
population’s aggregate use of antibiotics reflects 
what might be expected for the nation as a 
whole. 
Antibiotic use varied widely, however, across 
our four regions: highest in the Central region 
site, lowest in the Northeast sites. These vari- 
ations were not explained by income or other 
population differences. The symptoms or condi- 
tions for which our participants sought care 
























































































































































































































































































































































































































































































































































































































































































































































































































































































































436 BETSY FOXMAN et al. 
care per se) and variations in the type of physi- 
cian and his or her training may explain part or 
all of the site differences in antibiotic use; this 
question is currently under investigation. 
Was free care likely to increase antibiotic use 
nonspecificially or only for appropriate diag- 
noses? At the beginning of the experiment, 
families were randomly assigned to insurance 
plans, and we observed no differences by plan in 
the prevalence of over two dozen chronic condi- 
tions such as acne or several acute illnesses such 
as otitis media [20,21]. Hence, we would not 
expect the incidence of ailments for which anti- 
biotic treatment would be the norm to differ by 
plan. We observed, however, that antibiotic use 
was greater on the free than on the cost-sharing 
plans across all diagnoses, even those where 
antibiotic use is not beneficial (i.e. viral condi- 
tions). Thus, free care evidently had a general, 
nonspecific effect on increasing antibiotic use. 
Although antibiotics have unquestionable 
benefits, they also have adverse effects. We 
estimate using published rates [22] of adverse 
reactions associated with each antibiotic class 
that 5 serious adverse effects from antibiotics 
would have occurred per 1000 persons enrolled 
on the cost-sharing plans as compared with 10 
per 1000 on the free plan. For mild plus serious 
adverse effects the figures are 44 and 65 per 
1000 on the cost-sharing and free plans, re- 
spectively. Based on the physician’s reason for 
using an antibiotic, 18% of the possible serious 
adverse drug reactions (across all plans) would 
be associated with antibiotics given for viral 
conditions. Thus, cost-sharing reduced an in- 
dividual’s probability of suffering an adverse 
effect because the overall rate of antibiotic use 
was lower on cost-sharing plans. It did not, 
however, decrease the probability that an ad- 
verse reaction (if experienced) was caused by 
inappropriate use of the drug. 
As a possible strategy for dealing with inap- 
propriate antibiotic use, cost sharing falls short 
on two counts. On average, cost sharing lowered 
antibiotic use by 46%; although a considerable 
amount of inappropriate prescribing remained, 
the rate of appropriate use was also reduced to 
a similar degree. Thus, a more selective method, 
one that curtails inappropriate use while 
maintaining access to needed and appropriate 
antibiotics, is required. 
Clinically based programs, which teach physi- 
cians appropriate principles of antibiotic ther- 
apy, constitute one approach that should be 
tested more fully. Some programs of this sort 
have had limited success [23-251. Efforts to 
develop them further, with the aim of creating 
the desirable economic incentives of cost 
sharing without the attendant negative effects 
on access to needed care, should be strongly 
encouraged. 
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APPENDIX 
Negative Binomial Regression Model 
The negative binomial function offers an attractive basis 
for modeling the use of antibiotics by participants in the 
Health Insurance Experiment [15]. It allows us to explain 
the number of new prescriptions added by the ith individual 
in one year, n, as follows: 





I, = A, exp(xb) 
A, x r(0) 
(2) 
(3) 
i, = rate at which prescriptions are accumulated by 
i th person 
N = random variable 
r(0) = gamma distribution with parameters, 0 and 1(1, 
where $ is held constant. 
This model uses information on level of use (n,) and 
characteristics of the individual (x,) to estimate 6 and 8, 
Table Al. Negative binomial model predicting oral anti- 
biotic use 
Variable Coefficient 1 -test 
Intercept 
Cost-sharing 










Income x cost-sharing 
Age x income x cost-sharing 


















- 1.201 - 19.36 
Number of observations = 5043; log likelihood = 4859.4. 
which permit us to explain how elements of x, affect the level 
of n,. 
If A, were not distributed as a gamma distribution with 
parameter 0, but instead was constant and equal for all i, 
equations (2) and (3) together would define a Poisson model. 
We would have to make two important assumptions to use 
this simplified version of the model. First, additions are 
assumed independent of each other. Because our data do 
not indicate clustering, this assumption is not a bad approx- 
imation, Second, the mean and variance of the distribution 
of prescriptions should be equal to A for the Poisson to be 
a good approximation. This assumption is too restrictive. 
Instead of assuming all A, are equal to a common constant, 
we assume they are distributed according to a gamma dis- 
tribution, turning our model back into a negative binomial 
model. 
The negative binomial model works in the following way. 
A gamma distribution can represent a wide range of func- 
tions, depending on the value of 8, which is to be estimated. 
We can interpret A, as follows: For every person, we have 
a set of observable characteristics, x,, which affect antibiotic 
use. In addition for every person, there are characteristics 
we did not observe, and these factors also influence use. 
Therefore, we may have two persons with identical values 
of independent variables but with different levels of anti- 
biotic use. Different realizations, A, and A,, from the gamma 
distributions, r(0), may be assumed to be the reason for this 
unexplained difference in use levels of these observations. 
In drawing inferences, we cannot make different predic- 
tions for these two observations, but our inferences will 
indicate the general tendency of the use rate, given a set of 
values for the independent variables. Individuals will have 
different realizations of use rates around this general ten- 
dency according to a gamma distribution. In sum, this 
model incorporates our ignorance about decisions to use 
antibiotics by individuals but allows us to make inferences 
about the general tendency to use antibiotics. 
Table Al gives pertinent information about the final 
model used to generate the predictions shown in Table 5 of 
the main text. 
